Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis

PURPOSE: Although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (ON) after the completion of acute-phase treatment, especially anti-aquaporin 4 (AQP4) antibody-positive ON, and anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive ON, some patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Ophthalmol
Hauptverfasser: Mori, Sotaro, Kurimoto, Takuji, Murai, Yusuke, Ueda, Kaori, Sakamoto, Mari, Chihara, Norio, Yamada-Nakanishi, Yuko, Nakamura, Makoto
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883711/
https://ncbi.nlm.nih.gov/pubmed/33628473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8871146
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge